Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
05/19/20 dm A new Adult Febrile Neutropenia Powerplan is now available
May 20, 2020
From: "Danielle Mummert" <danielle.mummert@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Tuesday, May 19, 2020 11:48:43 AM
Subject: A new Adult Febrile Neutropenia Powerplan is now available
Good afternoon,
Background: A retrospective chart review of 37 adult patients presenting to Huntsville Hospital from January 2019 through December 2019 was performed. Results revealed vancomycin was utilized in a majority of these patients, without documented evidence of clinical need. Of those, the majority of patients were initiated on this regimen in the emergency department (ED).
Plan: Adult Febrile Neutropenia, a new powerplan, has been created and is now available to help reduce exposure to unnecessary antimicrobial treatment in adult patients with febrile neutropenia.
Important information:
Cefepime (Maxipime) will be automatically selected for antipseudomonal coverage. You may make adjustments to this order for patient specific presentation (i.e.-ESBL, penicillin allergy, and/or need for MRSA coverage).
Vancomycin is not indicated in all patients. It can be considered in the following settings:
Background: A retrospective chart review of 37 adult patients presenting to Huntsville Hospital from January 2019 through December 2019 was performed. Results revealed vancomycin was utilized in a majority of these patients, without documented evidence of clinical need. Of those, the majority of patients were initiated on this regimen in the emergency department (ED).
Plan: Adult Febrile Neutropenia, a new powerplan, has been created and is now available to help reduce exposure to unnecessary antimicrobial treatment in adult patients with febrile neutropenia.
Important information:
Cefepime (Maxipime) will be automatically selected for antipseudomonal coverage. You may make adjustments to this order for patient specific presentation (i.e.-ESBL, penicillin allergy, and/or need for MRSA coverage).
Vancomycin is not indicated in all patients. It can be considered in the following settings:
a. Suspected catheter related infection
b. Skin and soft tissue infection
c. Pneumonia
d. Hemodynamic instability (i.e. – sepsis)
Please let me know if you have any questions and/or concerns.
b. Skin and soft tissue infection
c. Pneumonia
d. Hemodynamic instability (i.e. – sepsis)
Please let me know if you have any questions and/or concerns.